| | 366789-02-8 Basic information More.. |
| Product Name: | Rivaroxaban | | Synonyms: | (S)-Rivaroxaban;5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide;BAY 59-7939;Rivaroxaban Isomer;Rivaroxaban;5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide;2-Thiophenecarboxamide, 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl];(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carboxami | | CAS: | 366789-02-8 | | MF: | C19H18ClN3O5S | | MW: | 435.88 | | EINECS: | 685-132-2 | | Mol File: | 366789-02-8.mol |  |
Use
Rivaroxaban was not carcinogenic when administered by oral gavage to mice or rats for up to 2 years. The systemic exposures (AUCs) of unbound rivaroxaban in male and female mice at the highest dose tested (60 mg/kg/day) were 1- and 2-times, respectively, the human exposure of unbound drug at the human dose of 20 mg/day. Systemic exposures of unbound drug in male and female rats at the highest dose tested (60 mg/kg/day) were 2- and 4-times, respectively, the human exposure.
Rivaroxaban was not mutagenic in bacteria (Ames-Test) or clastogenic in V79 Chinese hamster lung cells in vitro or in the mouse micronucleus test in vivo.
No impairment of fertility was observed in male or female rats when given up to 200 mg/kg/day of rivaroxaban orally. This dose resulted in exposure levels, based on the unbound AUC, at least 13 times the exposure in humans given 20 mg rivaroxaban daily.
- Rivaroxaban
-
- US $0.00-0.00 / KG
- 2024-07-22
- CAS:366789-02-8
- Min. Order: 1KG
- Purity: USP/EP WC+DMF D90 < 10um
- Supply Ability: 20 tons
- 366789-02-8
-
- US $100.00-60.00 / kg
- 2024-07-22
- CAS:366789-02-8
- Min. Order: 100kg
- Purity: 99.99%
- Supply Ability: 100Tons
- Rivaroxaban high quality
-
- US $60.00 / kg
- 2024-04-23
- CAS:366789-02-8
- Min. Order: 1kg
- Purity: 99.9%
- Supply Ability: 200000kg
|
|
366789-02-8
Recommend Suppliers |
|